ARCA Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
ARCA Biopharma Inc
TickerORKA
CIK #0000907654
CUSIP687604108
SectorLife Sciences - In Vitro & In Vivo Diagnostic Substances
Address8001 Arista Place Suite 200, Broomfield, CO 80021
Source [EDGAR]
CIK Filing 2011 - 2025
[0000907654] 10-K
[0000907654] 10-Q
[0000907654] 3
[0000907654] 4
[0000907654] 8-K
[0000907654] D
[0000907654] SC 13D
[0000907654] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Oruka Therapeutics Inc [2025-07-17] 0.0
RTW Investments LP Oruka Therapeutics Inc [2025-05-15] 0.0
Deep Track Capital LP Oruka Therapeutics Inc [2025-05-13] 0.0
FMR LLC Oruka Therapeutics Inc [2024-10-07] 0.0
Fairmount Funds Management LLC Oruka Therapeutics Inc [2024-09-06] 19.99
Venrock Healthcare Capital Partners III LP ARCA Biopharma Inc [2024-04-29] 5.2
Allostery Investments LP ARCA Biopharma Inc [2024-04-15] 7.3
Janus Henderson Group PLC ARCA Biopharma Inc [2024-04-11] 7.4
Avidity Partners Management LP ARCA Biopharma Inc [2024-04-09] 6.9
Adage Capital Management LP ARCA Biopharma Inc [2024-04-05] 8.28
Western Standard LLC ARCA Biopharma Inc [2023-09-11] 0.0
Funicular Fund LP ARCA Biopharma Inc [2022-03-28] 6.49
BML Investment Partners LP ARCA Biopharma Inc [2022-01-27] 5.3
Altium Capital Management LP ARCA Biopharma Inc [2020-06-10] 9.99
Sabby Management LLC ARCA Biopharma Inc [2020-06-01] 0.99
Renaissance Technologies LLC ARCA Biopharma Inc [2019-02-12] 5.88
Tekla Capital Management LLC ARCA Biopharma Inc [2016-02-12] 0.0
Franklin Resources Inc ARCA Biopharma Inc [2016-01-08] 17.9
Franklin Resources Inc ARCA Biopharma Inc [2015-07-09] 13.7
Growth Equity Opportunities IV LLC ARCA Biopharma Inc [2015-06-29] 21.3
Venrock Healthcare Capital Partners LP ARCA Biopharma Inc [2015-06-25] 17.1
RA Capital Management LLC ARCA Biopharma Inc [2015-06-25] 0.0
McCormack Riley ARCA Biopharma Inc [2013-10-07] 18.26
Sabby Management LLC ARCA Biopharma Inc [2013-06-03] 0.99
[2012-12-28] None
Atlas Venture Fund VII L P ARCA Biopharma Inc [2012-11-02] 12.0
Sabby Management LLC ARCA Biopharma Inc [2012-08-08] 5.83
Form 3/4/5 Filer 2011 - 2025
Oruka Therapeutics, Inc.
Sandler Laura Lee
Turtle Cameron
Ball Kristine M
Fairmount Healthcare Co-Invest III L.P.
Fairmount Funds Management LLC
Harwin Peter Evan
Kiselak Tomas
Fairmount Healthcare Fund II L.P.
Kulkarni Samarth
Dambkowski Carl
Shah Nimish P
Koh Bong Y
Venrock Healthcare Capital Partners III, L.P.
VHCP Co-Investment Holdings III, LLC
VHCP Management III, LLC
VHCP Management EG, LLC
Venrock Healthcare Capital Partners EG, L.P.
Goncalves Joana
Agarwal Arjun
Klein Lawrence Otto
Quinlan Paul T
Ma-Weaver Jacob
Janus Henderson Group PLC
Janus Henderson Biotech Innovation Master Fund Ltd
Mitchell Daniel J
Woosley Raymond L.
Grais Linda
Conway Robert E
Flynn James P
Hove Anders D
Funicular Funds, LP
Keuer Thomas A
Dekker C. Jeffrey
Funicular Fund, LP
Ozeroff Christopher David
Bristow Michael R
Selby Brian L.
VHCP Co-Investment Holdings II, LLC
VHCP Management II, LLC
Venrock Healthcare Capital Partners LP
VHCP Co-Investment Holdings, LLC
VHCP Management, LLC
Venrock Healthcare Capital Partners II, L.P.
Viswanathan Ravi
Sandell Scott D
Sakoda Jon
Mott David M
Makower Joshua
Florence Anthony A. Jr.
Baskett Forest
Barris Peter J
NEA Partners 15, L.P.
Growth Equity Opportunities Fund IV, LLC
NEA 15 GP LLC
New Enterprise Associates 15, L.P.
Sonsini Peter W.
Weller Harry R
Kolluri Krishna Kittu
mccormack riley
Wheeler Patrick M
Zabriskie John L
Atlas Venture Associates VII, L.P.
Atlas Venture Fund VII L P
Formela Jean Francois
Sobel Burton E
Brewer Richard B
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2025-06-30] DFND 5,616,471 5,616,471
VR Adviser LLC [2025-06-30] SOLE 4,148,428 4,148,428
Fairmount Funds Management LLC [2025-06-30] SOLE 3,371,922 3,371,922
BlackRock, Inc. [2025-06-30] SOLE 1,951,312 1,988,880
RTW Investments LP [2025-06-30] SOLE 1,945,649 1,945,649
Deep Track Capital LP [2025-06-30] SOLE 1,918,798 1,918,798
Vanguard Group Inc [2025-06-30] SOLE 0 1,794,684
Braidwell LP [2025-06-30] SOLE 1,524,842 1,524,842
Commodore Capital LP [2025-06-30] SOLE 1,419,714 1,419,714
Franklin Resources Inc [2025-06-30] DFND 1,012,968 1,012,968
Polar Capital Holdings Plc [2025-06-30] DFND 975,000 975,000
Mercer Global Advisors Inc /ADV [2025-06-30] SOLE 0 852,338
Blackstone Inc. [2025-06-30] OTR 0 826,724
Geode Capital Management LLC [2025-06-30] DFND 707,406 707,406
Affinity Asset Advisors LLC [2025-06-30] SOLE 603,479 603,479
Cable Car Capital LP [2025-06-30] SOLE 600,000 600,000
Frazier Life Sciences Management LP [2025-06-30] SOLE 583,327 583,327
SR One Capital Management LP [2025-06-30] SOLE 430,330 430,330
Woodline Partners LP [2025-06-30] SOLE 390,904 390,904
State Street Corp [2025-06-30] DFND 335,806 372,806
Price T Rowe Associates Inc /MD/ [2025-06-30] SOLE 372,503 372,503
Avidity Partners Management LP [2025-06-30] SOLE 352,124 352,124
Point72 Asset Management LP [2025-06-30] DFND 0 330,000
Northern Trust Corp [2025-06-30] DFND 218,026 218,026
Morgan Stanley [2025-06-30] DFND 207,523 208,328
SilverArc Capital Management LLC [2025-06-30] SOLE 165,389 165,389
Adar1 Capital Management LLC [2025-06-30] SOLE 142,780 142,780
Candriam S.C.A. [2025-06-30] SOLE 116,698 116,698
UBS Group AG [2025-06-30] DFND 110,646 110,646
Barclays PLC [2025-06-30] SOLE 91,164 91,164
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com